This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Karo Pharma Management
Management criteria checks 2/4
Key information
Christoffer Lorenzen
Chief executive officer
SEK 12.6m
Total compensation
CEO salary percentage
35.82%
CEO tenure
3.3yrs
CEO ownership
n/a
Management average tenure
2.2yrs
Board average tenure
2.5yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Christoffer Lorenzen's remuneration changed compared to Karo Pharma's earnings?
Date
Total Compensation
Salary
Company Earnings
Jun 30 2022
n/a
n/a
-SEK 190m
Mar 31 2022
n/a
n/a
-SEK 141m
Dec 31 2021
SEK 13m
SEK 5m
-SEK 17m
Sep 30 2021
n/a
n/a
SEK 63m
Jun 30 2021
n/a
n/a
SEK 2m
Mar 31 2021
n/a
n/a
SEK 49m
Dec 31 2020
SEK 12m
SEK 5m
SEK 82m
Sep 30 2020
n/a
n/a
SEK 86m
Jun 30 2020
n/a
n/a
SEK 87m
Mar 31 2020
n/a
n/a
SEK 55m
Dec 31 2019
SEK 16m
SEK 2m
SEK 9m
Compensation vs Market: Christoffer's total compensation ($USD1.20M) is below average for companies of similar size in the German market ($USD4.70M).
Compensation vs Earnings: Christoffer's compensation has increased whilst the company is unprofitable.
CEO
Christoffer Lorenzen (47 yo)
3.3yrs
Tenure
SEK 12,564,000
Compensation
Mr. Christoffer Lorenzen has been the Chief Executive Officer of Karo Pharma AB since July 1, 2019. Mr. Lorenzen was an Executive Vice President of Food Cultures & Enzymes at Chr. Hansen Holding A/S from A...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Christoffer Lorenzen
Chief Executive Officer
3.3yrs
SEK 12.56m
no data
Jon Johnsson
Chief Financial Officer
3.1yrs
no data
no data
Jonathan Kimber
Vice President of Operations
3.2yrs
no data
no data
Sofia Kyhlstedt
Vice President of Scientific Affairs
no data
no data
no data
Lisa Westerdahl
VP of Commercial Pharma Operations & Corporate Communications
no data
no data
no data
Anna Hale
Chief Marketing Officer
1.8yrs
no data
no data
Karin Lindberg
Head of People & Organization
2.5yrs
no data
no data
SIMON Nyberg-Hansen
Managing Director of Norway
no data
no data
no data
Fredrik Thorsen
Head of Digital & E-commerce
1.5yrs
no data
no data
Matt Roberts
Chief Commercial Officer
1.2yrs
no data
no data
Robin List
Chief Executive Officer of Sylphar
less than a year
no data
no data
Anna Elmblad
Vice President of Digital Marketing
no data
no data
no data
2.2yrs
Average Tenure
47yo
Average Age
Experienced Management: KA6N's management team is considered experienced (2.2 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Mark Keatley
Independent Director
1.6yrs
SEK 413.00k
no data
Uta Kemmerich-Keil
Independent Director
2.5yrs
SEK 394.00k
no data
Erika Henriksson
Director
3.8yrs
SEK 394.00k
no data
Flemming Ørnskov
Independent Director
3.1yrs
SEK 394.00k
no data
Kristofer Tonström
Independent Director
2.5yrs
SEK 394.00k
no data
Patrick Smallcombe
Independent Chairman
1.6yrs
SEK 552.00k
no data
Claire Hennah
Independent Director
less than a year
no data
no data
2.5yrs
Average Tenure
56yo
Average Age
Experienced Board: KA6N's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2022/11/27 09:24
End of Day Share Price
2022/11/24 00:00
Earnings
2022/06/30
Annual Earnings
2021/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Karo Pharma AB (publ) is covered by 3 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.